tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Vincent Chen, 4 are a HOLD (44.44%), 5 are a BUY (55.56%).
Analyst Vincent Chen, carries an average stock price target met ratio of 66.67% that have a potential upside of 14.74% achieved within 228 days. Previously, Vincent Chen worked at BERNSTEIN.
Vincent Chen’s has documented 21 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on IONS, Ionis Pharmaceuticals at 23-Mar-2021.
Analyst best performing recommendations are on BLUE (BLUEBIRD BIO).
The best stock recommendation documented was for IONS (IONIS PHARMACEUTICALS) at 2/20/2018. The price target of $55 was fulfilled within 21 days with a profit of $5.01 (10.02%) receiving and performance score of 4.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$70
$38.1 (119.44%)
$70
17 days ago
(15-Jan-2025)
0/10 (0%)
$36.73 (110.40%)
Buy
$60
$28.1 (88.09%)
$60
1 months 12 days ago
(20-Dec-2024)
0/14 (0%)
$24.41 (68.59%)
Hold
$55
$23.1 (72.41%)
$55
5 months 6 days ago
(26-Aug-2024)
2/4 (50%)
$8.2 (17.52%)
79
Sell
$37
$5.1 (15.99%)
$28
5 months 30 days ago
(02-Aug-2024)
3/5 (60%)
$-12.13 (-24.69%)
928
Hold
$51
$19.1 (59.87%)
$37
5 months 30 days ago
(02-Aug-2024)
6/7 (85.71%)
$1.87 (3.81%)
24
What Year was the first public recommendation made by Vincent Chen?
